169345 RESULTS

Anavex 2-73

THERAPEUTICS Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride Anavex Life Science Corp. Small Molecule Other This compound is an agonist of the sigma-1 chaperone protein, and in particular a mixed ligand to sigma1/muscarinic acetylcholine receptor ...

Postdoctoral Research Fellowships

JOB 2014-10-01 Employer University of California Irvine Description The University of California Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) is seeking postdoctoral research fellows. These fellowships are available throughout the year ...


THERAPEUTICS Janssen Pfizer PF-05236812 Immunotherapy (passive) Amyloid-Related Starting in September 2010, Pfizer and Janssen AIP conducted a double-blind Phase 1 trial with an open-label extension at centers in the United States and South Korea. The adaptive trial ...


THERAPEUTICS AstraZeneca Immunotherapy (passive) Amyloid-Related In February 2014, AstraZeneca started a multicenter Phase 1 trial in the United States, which is to enroll 242 people with mild to moderate Alzheimer's disease. The study will evaluate single and ...


THERAPEUTICS Eli Lilly & Co. N3pG-Aβ Monoclonal Antibody Immunotherapy (passive) Amyloid-Related In May 2013, Lilly started a Phase 1 study in 100 people on the spectrum of mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From